89 related articles for article (PubMed ID: 2097266)
1. Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma.
Cazzola M; Bergamaschi G; Melazzini M; Ponchio L; Rosti V; Molinari E
Haematologica; 1990; 75(5):477-9. PubMed ID: 2097266
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
3. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
Casini M; Pianezze G; Fabris P; Cemin S; Coser P
Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
[No Abstract] [Full Text] [Related]
4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia following radiotherapy for carcinoma of the cervix: report of a case and brief review of the literature.
Ural AU; Beyzadeoglu M; Avcu F; Nevruz O
Am J Hematol; 2007 May; 82(5):415-6. PubMed ID: 17133425
[No Abstract] [Full Text] [Related]
6. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
[TBL] [Abstract][Full Text] [Related]
7. [Second neoplasms in malignant hematologic disorders. Experience from 1978 to 1987].
Cristoffanini A; Zapata C; León A; Salas P
Rev Med Chil; 1990 May; 118(5):522-9. PubMed ID: 2293272
[TBL] [Abstract][Full Text] [Related]
8. [Secondary malignant tumors following treatment of Hodgkin's disease].
Shishkin IP
Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
[TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
Kiene J; Sezer O; Rasche H; Klempa I
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():244-6. PubMed ID: 9101844
[TBL] [Abstract][Full Text] [Related]
11. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Young RC; Longo DL; Glatstein E; Ihde DC; Jaffe ES; DeVita VT
Semin Hematol; 1988 Apr; 25(2 Suppl 2):11-6. PubMed ID: 2456618
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
[No Abstract] [Full Text] [Related]
13. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
[TBL] [Abstract][Full Text] [Related]
14. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
Henry-Amar M
J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
[TBL] [Abstract][Full Text] [Related]
15. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
Abdyldaev RA; Kruglova GV
Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
[TBL] [Abstract][Full Text] [Related]
16. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
Lyman GH; Delgado DJ
Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
[TBL] [Abstract][Full Text] [Related]
17. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
